Urology News and Research

Latest Urology News and Research

FDA approves Actavis' ANDA for Telmisartan Immediate-Release Tablets

Actavis plc today announced that it has received approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a generic equivalent to Boehringer Ingelheim's Micardis. Actavis intends to launch the product immediately.

9 Jan 2014

ArthroCare enters into Deferred Prosecution Agreement with the U.S. Department of Justice

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, and the U.S. Department of Justice entered into a Deferred Prosecution Agreement filed today with the United States District Court in the Western District of Texas (the Court).

8 Jan 2014

Fetal exposure to Bisphenol A can increase risk for prostate cancer later in life

Fetal exposure to a commonly used plasticizer found in products such as water bottles, soup can liners and paper receipts can increase the risk for prostate cancer later in life, according to a study from the University of Illinois at Chicago published Jan. 7 online in the journal Endocrinology.

8 Jan 2014

Mylan launches Tolterodine Tartrate ER Capsules, 2 mg and 4 mg

Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Tolterodine Tartrate Extended-release Capsules, 2 mg and 4 mg. Tolterodine Tartrate ER Capsules are the generic version of Pfizer's Detrol LA, and are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.

7 Jan 2014

ERYTECH proposes to broaden lead product in solid tumors, begins Phase II study in pancreatic cancer

ERYTECH Pharma (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, provides an update on its development plans to broaden the scope of its lead product ERYASP into the large field of solid tumors and announces the launch of a Phase II study in pancreatic cancer.

7 Jan 2014

New guidelines provide screening recommendations for people at higher risk of developing lung cancer

Alarmingly, more than 200,000 Americans will be diagnosed with lung cancer this year and nearly 160,000 people will die of the disease. In fact, according to the American Cancer Society, lung cancer takes more lives each year than colorectal, breast and prostate cancers combined.

7 Jan 2014

SUI and UUI show complex interrelationship

A study by US researchers has failed to identify any modifiable risk factors for urgency urinary incontinence among women undergoing surgery for stress urinary incontinence.

6 Jan 2014

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Astellas Pharma Inc. (Astellas) and ClearPath Development Company (ClearPath) announced today a strategic partnership to form a portfolio of development companies focused on vaccines targeting infectious diseases.

6 Jan 2014

Metabolon raises $15 million in Series E financing

Metabolon, Inc., a world leader in metabolomics-based diagnostic tests and research services, announced today that it has raised $15 million in a Series E financing through the issuance of preferred stock.

3 Jan 2014

Apple Valley Medical Clinic Sleep Center moves to 14843 Energy Way in Apple Valley

The Apple Valley Medical Clinic's Sleep Center has moved to 14843 Energy Way in Apple Valley. The center, which opened in 2010 under the medical direction of Scott Benson, M.D., a family medicine physician with the Apple Valley Medical Clinic, offers preventive care, diagnosis and referral for treatment of sleep disorders.

3 Jan 2014

Actavis' subsidiary files ANDA for generic version of NuvaRing

Actavis plc today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Ethinyl Estradiol and Etonogestrel Vaginal Ring, 0.015 mg/24 hour and 0.12 mg/24 hour.

26 Dec 2013

Actavis' subsidiary receives FDA complete response letter for progestin-only patch NDA

Actavis plc today confirmed that the Company's subsidiary has received a complete response letter from the U.S. Food and Drug Administration for its New Drug Application for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy.

24 Dec 2013

Young women more likely to have negative urodynamics experience

Research from the USA suggests that while urodynamic testing is well-tolerated by women on the whole, patients who are younger, or have anxiety or depression may have more negative experiences of the procedure than other patients.

24 Dec 2013

Low testosterone levels linked to nocturia in men

Research from South Korea indicates that low testosterone levels are associated with nocturia in men, independent of both age and prostate volume.

24 Dec 2013

Researchers start first cancer operation room with navigator

A team of researchers from Gregorio Marañón Hospital, the company GMV and the Universidad Carlos III de Madrid (UC3M) have started the first cancer operation room with a navigator. This image-guided system will allow for increased intraoperative radiotherapy safety.

22 Dec 2013

Pelvic radiation therapy to treat uterine cancer may increase risk of developing bladder cancer

Radiation therapy used to treat uterine cancer may increase a patient's risk of developing bladder cancer. That is the conclusion of a recent study published in BJU International.

18 Dec 2013

Researchers identify new technique to reduce postoperative pain in children

...

18 Dec 2013

Study provides important new perspective on how we look at bladder cancer biology

Bladder cancer will kill upward of 170,000 people worldwide this year, but bladder cancer isn't fatal in the bladder. Instead, in order to be fatal the disease must metastasize to faraway sites. The question has been this: does localized, non-muscle invasive bladder cancer eventually become the more dangerous, muscle-invasive form of the disease, or are NMI and MI bladder cancers genetically distinct from the start?

17 Dec 2013

New report shows death rates for lung cancer dropping at a faster pace

The Annual Report to the Nation on the Status of Cancer, covering the period 1975, showed death rates for lung cancer, which accounts for more than one in four cancer deaths, dropping at a faster pace than in previous years. The recent larger drop in lung cancer deaths is likely the result of decreased cigarette smoking prevalence over many years, and is now being reflected in mortality trends. The lung cancer death rate decline, as well as declines in colorectal, breast, and prostate cancer death rates, has also helped drive decreases in death rates for all cancers types combined, a trend that began about 20 years ago.

17 Dec 2013

Targacept reports top-line results from TC-5619 Phase 2b trial for negative symptoms in schizophrenia

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced top-line results from a Phase 2b clinical trial of TC-5619 as an augmentation therapy for the treatment of negative symptoms of schizophrenia.

17 Dec 2013

Urology News and Research

Latest Urology News and Research

FDA approves Actavis' ANDA for Telmisartan Immediate-Release Tablets

ArthroCare enters into Deferred Prosecution Agreement with the U.S. Department of Justice

Fetal exposure to Bisphenol A can increase risk for prostate cancer later in life

Mylan launches Tolterodine Tartrate ER Capsules, 2 mg and 4 mg

ERYTECH proposes to broaden lead product in solid tumors, begins Phase II study in pancreatic cancer

New guidelines provide screening recommendations for people at higher risk of developing lung cancer

SUI and UUI show complex interrelationship

Astellas, ClearPath announce strategic partnership to develop vaccine for infectious diseases

Metabolon raises $15 million in Series E financing

Apple Valley Medical Clinic Sleep Center moves to 14843 Energy Way in Apple Valley

Actavis' subsidiary files ANDA for generic version of NuvaRing

Actavis' subsidiary receives FDA complete response letter for progestin-only patch NDA

Young women more likely to have negative urodynamics experience

Low testosterone levels linked to nocturia in men

Researchers start first cancer operation room with navigator

Pelvic radiation therapy to treat uterine cancer may increase risk of developing bladder cancer

Researchers identify new technique to reduce postoperative pain in children

Study provides important new perspective on how we look at bladder cancer biology

New report shows death rates for lung cancer dropping at a faster pace

Targacept reports top-line results from TC-5619 Phase 2b trial for negative symptoms in schizophrenia

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Urology News and Research

Latest Urology News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in